Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats

Area of Science:

• Cardiovascular Physiology
• Gastroenterology

Background:

• Portal hypertension is associated with hyperdynamic circulation.
• Elevated serum bile acids (BAs) are observed in portal hypertension and possess vasodilatory properties.
• BAs are hypothesized to mediate the hyperdynamic circulation in portal hypertension.

Purpose of the Study:

• To investigate the role of serum bile acids (BAs) in mediating hyperdynamic circulation in portal hypertension.
• To determine if reducing circulating BA levels impacts key hemodynamic parameters in a rat model.

Main Methods:

• Utilized a rat model of portal hypertension induced by partial portal vein ligation (PVL).
• Administered cholestyramine (PVL-CH) to reduce circulating BAs or Metamucil suspension (PVL-ME) as a control.
• Measured systemic and splanchnic hemodynamic parameters including mean arterial pressure, portal pressure, cardiac index, and blood flow.

Main Results:

• No significant differences were observed in mean arterial pressure, portal pressure, cardiac index, splanchnic blood flow, or portosystemic shunting between PVL-CH and PVL-ME groups.
• Peripheral and splanchnic arteriolar resistances also showed no significant variation between the two groups.
• Serum BA levels were significantly lower in the PVL-CH group (25 +/- 4 microM/l) compared to the PVL-ME group (84 +/- 9 microM/l).

Conclusions:

• Reducing circulating bile acids with cholestyramine did not alter the hyperdynamic systemic and splanchnic circulation in portal hypertensive rats.
• These findings suggest that elevated bile acids may not be the primary mediators of hyperdynamic circulation in this model of portal hypertension.